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Background: Premenstrual dysphoric disorder (PMDD), characterized by luteal phase-induced negative affect and
loss of impulse control, often results in compromised social interactions. Although amygdala activation is generally
linked to negative affect, increased amygdala reactivity to aversive stimuli in the luteal phase has not been consistently
reported in PMDD. We tested the hypothesis that amygdala hyper-reactivity in PMDD is symptom specific, rather than
generalized, and linked to socially relevant stimuli. Blood oxygenation level dependent signal changes during exposure
to negative images with social and non-social content were evaluated in the mid-follicular and late luteal phase of the
menstrual cycle. Fourteen women with PMDD and 13 healthy controls participated.
Results: When compared with healthy controls, women with PMDD in the luteal phase had enhanced reactivity to
social stimuli compared to non-social stimuli in the amygdala and insula, but attenuated reactivity in the anterior
cingulate cortex. Functional couplings between emotion processing and controlling areas were significantly
different, being positive in women with PMDD and negative in healthy controls. Changes in progesterone levels
in women with PMDD correlated positively with altered amygdala reactivity.
Conclusions: Socially relevant aversive stimulation elicited enhanced activity in affective processing brain regions
that were functionally coupled to compromised activity in cognitive control areas. Because increased reactivity
correlated positively with alterations in ovarian steroid levels, data preliminary support the hypothesis that
enhanced progesterone sensitivity in PMDD affects corticolimbic processing of social emotions.Background
Premenstrual dysphoric disorder (PMDD), characterized
by luteal phase-induced anxious and depressive symptoms
as well as emotional lability [1], affects around 5% of
women of reproductive age [2]. The symptomatology
compromises quality of life, including social interactions
[3]. Because the core symptoms of PMDD are affective in
nature, it has been suggested that brain areas in the fear
circuit [4], particularly the amygdala, mediate PMDD
symptoms [5]. The amygdala, insula and anterior cingulate
cortex (ACC) form a hypothesized corticolimbic emotion* Correspondence: malin.gingnell@psyk.uu.se
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unless otherwise stated.processing network [4,6], with the amygdala and insula
activated by bottom-up emotional processes, and the ACC
involved in top-down regulation [4,7]. Although increased
amygdala reactivity characterizes negative affective states
like anxiety and depression [8-15], studies on amygdala
reactivity in PMDD are inconsistent [16-18]. Protopopescu
et al. [16] reported increased amygdala reactivity in
response to emotional words, but their results reflected
alterations in reactivity over the menstrual cycle in healthy
controls rather than in women with PMDD. Gingnell
et al. [17] also reported a luteal phase-induced increase in
amygdala reactivity to emotional faces, but only among a
subgroup of patients with PMDD with high trait anxiety
[17]. Furthermore, Gingnell et al. [18] observed increased
reactivity to negative emotional stimuli in the amygdala
and insula, but no differences between patients and con-
trols and with no menstrual phase modulation.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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altered emotional reactivity. In post-traumatic stress dis-
order (PTSD), for example, increased amygdala reactivity
and decreased activity in emotion controlling areas is
observed not only in response to trauma-related challenge
but also to non-symptomatic stimulation such as aversive
emotional faces, even outside awareness [19-21]. By con-
trast, in other disorders like specific phobia, amygdala
hyper-reactivity is circumscribed to phobic cues and ab-
sent in response to other emotionally relevant situations
[22]. It has not been determined if amygdala reactivity in
women with PMDD reflects a generally altered emotional
responsivity or whether exaggerated amygdala reactivity is
specific to symptomatic challenges. PMDD symptoms
compromise everyday social functions both at work
and at home, resulting in frequent reports of disrupted
interpersonal interactions [23]. Although it is uncertain
if partner violence is a significant risk factor for PMDD
[24-26], both women with a history of trauma and with
PTSD are more likely to experience PMDD, especially
when trauma exposure involves interpersonal violence
[27,28]. In addition, women with PMDD with a history
of trauma have abnormal neuroendocrine stress responses
compared to women with PMDD without a trauma
history [24-26,29].
Because PMDD symptoms affect social interactions and
perceived social threat might be crucial for the develop-
ment of the disorder, it is conceivable that enhanced
amygdala reactivity is elicited mainly by socially relevant
stimuli. Emotional words and general emotional stimuli
[16,17] might not tap into PMDD symptomatology, and
therefore not increase amygdala reactivity. If so, mixing
generally emotion-arousing stimulation with more focused
symptomatic challenges may produce inconsistent results,
such as those previously reported [16-18]. Furthermore,
even though the amygdala has a key role in anxiety and
negative affect, both theoretical reasoning [30] and em-
pirical results [8,15] support that other areas in the fear
circuit [4], such as the insula, and cognitive control areas,
like the ACC, are involved in emotional processing.
We hypothesized that socially relevant stimulation is
a prime elicitor of negative affect in PMDD, reflected
in corticolimbic circuit functions with increased brain
reactivity in the affective processing regions of the
amygdala and insula [4,6-8,15,30], as well as decreased
reactivity in the regulatory ACC region [31] and an altered
functional coupling between the processing and regulatory
areas [31]. Because PMDD symptoms include negative
emotional symptoms that are experienced in the luteal
but not the follicular phase of the menstrual cycle, altered
reactivity and connectivity should be evident predomin-
antly in the luteal phase and possibly coupled to variations
in ovarian steroid hormones [5,32]. This hypothesis was
tested by evaluating brain reactivity and connectivity usingfunctional magnetic resonance imaging (fMRI) of blood
oxygenation level-dependent (BOLD) activity to social
and non-social negative stimuli in the follicular and luteal
phase of the menstrual cycle in women with PMDD and
healthy controls. We also explored if ovarian steroid
hormones correlated with corticolimbic circuit functions.
Methods
We re-analyzed data from a study including social and
non-social aversive emotional pictures [18]. The original
paradigm included exposure to emotional images of nega-
tive or positive valence. All emotional-image slides were
proceeded either by a red cue, signaling negative affect, or
a green, associated with positive pictures. The timing was
such that the color cue was displayed 5 s before a 2 s ex-
posure of the social slide, and followed by a 2.5 to 3.5 s
black screen with a inter-trial interval of 9 to 11 seconds.
The emotional stimuli, 15 negative and 15 positive
pictures, were selected from the International Affective
Pictures System (IAPS) [33]. For an example of the para-
digm see Additional file 1. We analyzed BOLD responses
to socially relevant and irrelevant negative emotional stim-
uli. Negative stimuli were chosen because PMDD mainly
comprises negative emotional symptoms [1].
Participants
Seventeen women with PMDD and 16 asymptomatic
controls were recruited through a newspaper advertise-
ment and from women with a PMDD diagnosis.
PMDD was diagnosed according to the definitions in
the Diagnostic and Statistical Manual of Mental Disorders
IV [1]. Details of the diagnostic procedure have been
described previously [34]. Briefly, prospective ratings of
daily symptoms using the Cyclicity Diagnoser (CD-scale)
were completed to confirm the presence of PMDD and to
estimate the severity of PMDD symptoms. The number of
days during the 10 days before menses when participants
reported a score of 2 or more on the CD-scale for each of
the the four core symptoms of PMDD (irritability, depres-
sion, anxiety and mood swings) (i.e. a scale 0–40) [35],
and number of days when social interaction was avoided
(0 to 10) were used as measures of PMDD severity. The
asymptomatic controls were physically healthy women
with regular menstrual cycles and no history of premen-
strual dysphoric symptoms. None of the controls reported
premenstrual dysphoric symptoms on daily ratings. The
study was approved by the Ethical Review Board of Upp-
sala, Sweden, and all participants gave written informed
consent.
Exclusion criteria were pregnancy; treatment with hor-
monal compounds or psychotropic drugs; or presence
of any ongoing psychiatric disorder. Absence of other
psychiatric disorders was confirmed using the structured
psychiatric interview, Mini International Neuropsychiatry
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cardiac defibrillators, aneurysm clips, cochlear implants or
other implants including magnets, batteries or wires were
excluded. One woman with PMDD and one healthy control
dropped out after the first scanning session due to personal
reasons, and two healthy controls and three women with
PMDD were excluded due to movement artifacts (peaks of
movement in the x/y/z-axis of more than 3 mm or more
than 2 degrees of rotation), or incomplete scanning sessions
due to hardware problems. There were no significant differ-
ences in demographic or behavioral data between excluded
and remaining participants. Fourteen women with PMDD
and 13 healthy controls were analyzed.
Timing according to the menstrual cycle
fMRI scanning was performed twice, once in the mid-
follicular phase (6 to 12 days after the onset of menstrual
bleeding) and once to coincide with the late luteal phase
(postovulatory day 8 to 13), according to a positive lutein-
izing hormone assay (Clearplan, Unipath, Bedford, UK).
Monitoring of the luteal phase was confirmed by pro-
gesterone serum concentrations and records of the next
menstrual bleeding. The study was counterbalanced across
the menstrual cycle with half of the participants scanned
first in the follicular phase and then in the luteal phase,
and the other half scanned in the reverse order.
Hormonal analyses
Blood samples were drawn before each scanning. Estradiol
and progesterone serum concentrations were determined
by competitive immunometric electrochemistry lumines-
cence detection at the Department of Clinical Chemistry,
Uppsala University Hospital. The samples were run on a
Roche Cobas e601 with Cobas Elecsys reagent kits (Roche
Diagnostics, Bromma, Sweden). The measurement inter-
val was 0.1 to 191 nmol/l for progesterone and 18.4 to
15,781 pmol/l for estradiol. The progesterone intra-
assay coefficient of variation was 2.21% at 2.39 nmol/l
and 2.82% at 31.56 nmol/l. The estradiol intra-assay co-
efficient of variation was 6.8% at 85.5 pmol/l and 2.8%
at 1,640 pmol/l.
Mood and anxiety scales
Prior to each fMRI scan, participants completed the self-
rated version of the Montgomery-Åsberg Depression Rat-
ing Scale (MADRS-S) [37] and the state portion of the
Spielberger State-Trait Anxiety Inventory (STAI-S) [38].
Functional magnetic resonance imaging - scans
and paradigm
fMRI was performed using a 3 T whole body scanner
(Achieva 3 T X Philips scanner Philips Medical Systems,
Best, The Netherlands) equipped with an eight-channel
head coil. At the beginning of each scanning session, ananatomical T1-weighted reference data set to a voxel size
of 0.8 × 1.0 × 2.0 mm3 and 60 slices were acquired. During
stimulus presentations, BOLD imaging was performed
using a single shot echo-planar imaging sequence with
parameters echo time/repetition time 35/3,000 ms, flip
angle 90°, acquisition matrix 76 × 77, acquired voxel
size 3.0 × 3.0 × 3.0 mm3 and 30 slices.
The participants lay facing upwards in the scanner with
their heads lightly fixated. Visual stimuli were presented
through goggles mounted on the head coil (VisualSystem,
NordicNeuroLab, Bergen, Norway). The stimulus para-
digm was implemented using the commercial software
package E-prime (Psychology Software Tools, Sharpsburg,
PA, USA). To synchronize the paradigm and the MR
sequence, a SyncBox (NordicNeuroLab) was used. The
paradigm included 15 negative pictures selected from
the IAPS [33] preceded by a color cue indicating the
valence. We compared the eight slides displaying negative
social situations (for example, injured humans, abduction
of a young female; IAPS: 3320, 2710, 3051, 3160, 6312,
6570, 8230, 9042) with the seven pictures containing nega-
tive, but non-social stimuli (for example, snakes, threaten-
ing dogs; IAPS: 1050, 1052, 1111, 1201, 1274, 1525, 9620).
After scanning, participants again viewed and rated pic-
tures for valence and arousal using the Self-Assessment
Manikin used in the IAPS material [33]. Arousal ratings
are available in Additional file 2 but are not included
here, as we did not test any arousal-related hypotheses.
The valence ratings for social and non-social stimuli
were analyzed in a Group by Phase analysis of variance,
with additional follow-up t-tests.
Functional magnetic resonance imaging - preprocessing
and analysis
The Digital Imaging and Communications in Medicine
images from the scanner were converted to Neuroimaging
Informatics Technology Initiative files using the freeware
package MRicron [39]. The data were then analyzed in
MatLab (MathWorks, Natick, MA, USA) using SPM5
[40]. The individual BOLD images were realigned to a
mean image for the session, slice timed to the middle
slice of each whole brain volume, co-registered with
the individual anatomic scan, normalized into Montreal
Neurological Institute (MNI) coordinates space using
normalization parameters obtained from a segmentation
into the white matter, grey matter and cerebrospinal fluid
of the individual anatomical scan, and smoothing was
performed using an 8 mm kernel.
For each individual, BOLD signal changes in the fMRI
time series were regressed on to social and non-social
negative images. Onsets and durations for stimuli included
in the paradigm but not analyzed in the present study (that
is, anticipatory periods, positive emotional stimuli) and the
six movement parameters obtained in the realignment step
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for each individual of the contrast between social and
non-social negative images. These contrast maps were
then used for group comparisons. Analyses of group
differences were first performed to compare women with
PMDD and healthy controls during the luteal phase.
Regions of interest (ROIs) were generated using the
automatic anatomical labeling definitions in the Wake
Forest University School of Medicine PickAtlas [41-43]
and included the bilateral amygdala, insula and ACC.
Then, a ROI defined by the group differences observed in
the luteal phase was used for between-group comparisons
in the follicular phase and for within-group comparisons
between phases. To test the a priori hypothesis of increased
reactivity in the amygdala and insula as well as attenuated
reactivity in the ACC in PMDD during the luteal phase, an
uncorrected p-value of 0.05 with k ≥5, corrected for the
search volume of each ROI, was used. Functional couplings
during the luteal phase between the amygdala and the
insula, respectively, to the ACC, were evaluated with
extracted data from the significant clusters, as defined
by the between-participants effects in the luteal phase, used
as seeds for correlations. These analyses were performed in
each group separately. The relatively lenient statistical
threshold was deliberately chosen as we restricted analyses
only to ROIs where specific hypotheses were advanced.
This approach does not only focus on type I errors but also
gives a balance between type I and type II errors [44,45].
Self-reports and affective picture ratings were compared
by paired and independent t-tests, respectively. Estradiol
and progesterone levels were compared using Mann-
Whitney U test and Wilcoxon signed rank tests, respect-
ively. Symptom severity and number of days when social
interaction was avoided were evaluated using Student’s
t-tests. In addition, partial correlations adjusted for af-
fective ratings were performed between alterations in
brain reactivity and change in ovarian steroid hormone
levels (follicular to luteal phase) to evaluate if brain ac-
tivity was tied primarily to changes in hormonal activity
or subjective ratings.
Results
Demographics and hormonal results
No significant group differences emerged for age (PMDD
35.0 ± 8.9 years; healthy controls 33.1 ± 7.8 years; t(25) =
0.6; p = 0.56), day of testing in the follicular phase (PMDD
8.5 ± 1.9; healthy controls 10.1 ± 3.5; t(25) = 1.8; p = 0.084),
or luteal phase (PMDD −4.6 ± 3.8, healthy controls −4.4 ±
2.7; t(25) = 0.35; p = 0.73). Similarly, hormonal levels did
not differ between groups for follicular phase progesterone
(U = 52.5, p = 0.062), luteal phase progesterone (U = 68.0,
p = 0.28), follicular phase estradiol (U = 75.0, z = −0.77,
p = 0.44) and luteal phase estradiol (U = 77.5, z = −0.66,
p = 0.51). Estradiol levels were similar in the follicularand luteal phase in both groups (for both groups Z <0.87,
p >0.38). However, progesterone increased significantly
from the follicular to the luteal phase in both groups
(healthy controls Z = 2.9, p = 0.004; and PMDD Z = 3.3;
p = 0.001; Figure 1).
Behavioral results
Women with PMDD had higher MADRS-S and STAI-S
scores during the luteal compared to the follicular phase
(t(13) = 2.7, p = 0.017 and t(13) = 2.5, p = 0.027, respect-
ively) whereas in healthy controls luteal phase ratings did
not differ from the follicular phase (for both measures
t(13) <1.1, p >0.27). When compared to healthy con-
trols, women with PMDD scored higher on MADRS-S
(t(25) =5.4, p <0.0001) and STAI-S (t(25) =5.7, p <0.0001)
in the luteal phase but not in the follicular phase (for both
measures t(25) <1.8, p >0.078; Figure 2). Women with
PMDD had a symptom severity of 27.9 ± 2.3 (range 0 to
40) [35] and avoided social interaction during 5.1 ± 1.0 out
of 10 premenstrual days. Corresponding values for healthy
controls were 8.1 ± 2.5 and 1.3 ± 0.6, respectively. The
group differences were statistically significant for both
measures (symptom severity: t(25) =5.6, p <0.0001; avoid-
ing social interaction: t(25) = 3.2, p = 0.003.
For valence ratings, the only significant difference was
found for ratings of social stimuli in the luteal phase
(F = 6.62, p = 0.017). Women with PMDD rated the social
images significantly more negative than healthy controls
during the luteal phase (t(24) =2.5, p = 0.021; Figure 3) but
not in the follicular phase (t(25) =1.2, p = 0.24). Also,
women with PMDD rated the social stimuli as more
negative than the non-social stimuli both in the follicular
(t(13) =3.4, p = 0.005) and the luteal phase (t(13) =4.3,
p = 0.001; Figure 3), whereas healthy controls gave similar
ratings for social and non-social stimuli during both
phases (both phases t (13) <1.6, p >0.14). Arousal ratings
are available in the Additional file 2: Table S1.
Brain results
Between group comparisons of reactivity
During the luteal phase, women with PMDD had higher
reactivity to social stimuli than healthy controls in the
amygdala (−21, 2, −15; k = 11; z = 2.18; p = 0.015) and
insula (45, −9, −2; k = 10; z = 2.13; p = 0.016), but lower
reactivity in the ACC (two clusters: 9, 33, 23; k = 12; z =
2.22; p = 0.013; and 3, 50, 11; k = 27; z = 3.23; p = 0.001)
(Figure 4). No group differences were observed in the fol-
licular phase. The contrast between non-social and social
images revealed no group differences in either phase.
Within group comparisons of reactivity
In women with PMDD, There was higher amygdala
reactivity to social than non-social stimuli in the luteal
as compared to the follicular phase (−21, 2, −15; k = 5;
Figure 1 Hormone levels. (A) Progesterone and (B) estradiol levels in women with PMDD and healthy controls during the follicular and luteal
phase of the menstrual cycle. In both groups, progesterone increased significantly in the luteal phase whereas estradiol was similar across phases.
No significant group differences emerged in either phase. **p <0.001. HC, healthy controls; PMDD, premenstrual dysphoric disorder.
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healthy controls.
Connectivity
Connectivity analyses revealed a pattern of positive con-
nectivity between BOLD reactivity in emotion processing
and controlling areas in PMDD (amygdala and ACC: 6,
45, 23; k = 5; z = 2.39; p = 0.008; and insula and ACC: 9,
33, 23; k = 6; z = 2.62; p = 0.004) whereas there was a trend
towards a negative relation between the ACC and insula
in healthy controls (6, 33, 23; k = 1; z = 1.74; p = 0.041).
The pattern was identical when three outliers in BOLD
reactivity (>2 SD from mean of group) were removedFigure 2 Depression and anxiety ratings. (A) MADRS-S and (B) STAI-S se
the follicular and luteal phase of the menstrual cycle. Women with PMDD
higher in the luteal than the follicular phase. No significant group differenc
phases. *p <0.05; **p <0.001. MADRS-S, Montgomery-Åsberg Depression Ra
self-rated version PMDD, premenstrual dysphoric disorder; HC, healthy con(Figure 5). The correlation strength between the insula
and the ACC differed significantly between PMDD and
healthy controls (z = 2.99; p = 0.0027).
Correlations with brain reactivity, ovarian steroids and
affective ratings
For women with PMDD, the phase-related increase in
amygdala reactivity to social as compared to non-social
stimuli correlated positively with the corresponding change
in progesterone level (rxy = 0.61, P = 0.020). When partializ-
ing out the valence ratings, the correlation between proges-
terone and amygdala remained (rxy = 0.63, P = 0.020).lf-report ratings for women with PMDD and healthy controls during
had higher scores than healthy controls during the luteal phase and
es were present in the follicular phase or for healthy controls between
ting Scale - self-rated version; STAI-S, State-Trait Anxiety Inventory -
trols.
Figure 3 Valence ratings in the luteal phase. Women with PMDD
rated images with social content as more negatively valenced than
images with a non-social content, and rated social stimuli as more
negative than did healthy controls. There were no group differences
for ratings of non-social stimuli. *p <0.05, **p <0.001. HC, healthy
controls; PMDD, premenstrual dysphoric disorder.
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We tested the hypothesis that women with PMDD are
overly sensitive to negative social stimulation rather than
generally affected by negative emotional stimuli and that
this would be reflected in altered corticolimbic processing.
Subjective reports confirmed an anxious and depressiveFigure 4 BOLD reactivity. Patients with PMDD had enhanced reactivity to
of interest, the (A) left amygdala (−21, 2, −15; k = 11; z = 2.18; P = 0.015) and (B
to healthy controls in the luteal phase. (C) Women with PMDD also had atten
marked in red and yellow respectively (9, 33, 23; k = 12; z = 2.22; p = 0.013; and
in Talairach coordinates. Brighter colors represent higher t scores. Below the b
cluster. Healthy controls are given in the left panels and PMDD to the right. Astate of mind, and sensitivity to social stimulation, in
women with PMDD during the luteal phase. The negative
feeling state was coupled to exaggerated reactivity in the
amygdala and insula and attenuated reactivity in ACC re-
gions projecting to the amygdala [46]. Amygdala reactivity
was also higher in the luteal than the follicular phase.
Collectively, data preliminary support the hypothesis that
increased sensitivity to social stimulation characterizes
PMDD and that corticolimbic circuit activity is altered
more by socially relevant than irrelevant stimuli. Thus,
previous inconsistent results on amygdala reactivity in
PMDD [16-18] may reflect the use of a mixture of social
and non-social stimuli.
The connectivity pattern must be regarded as prelim-
inary due to the small sample size. Previous studies have
reported functional couplings between the amygdala and
the ACC [46] as well as between the ACC and insula
[47,48]. The theoretically predicted negative functional
couplings with enhanced reactivity in emotion process-
ing areas associated with reduced reactivity in emotion
regulating areas [31], consistent with top-down emo-
tional control, was observed in healthy controls. By con-
trast, and in line with the hypothesis, women with
PMDD displayed an aberrant connectivity pattern with
positive couplings between both amygdala and insula
reactivity on the one hand and ACC on the other, indi-
cating the primacy of bottom-up processes. In socialsocially relevant stimuli as compared to non-social stimuli in two regions
) the right insula (45, −9, −2, k = 10, z = 2.13, p = 0.016) when compared
uated reactivity to social stimuli in the midline ACC in two clusters
3, 50, 11; k = 27; z = 3.23; p = 0.001). All anatomic localizations are given
rain images, contrast estimate plots are given for the peak voxel of each
CC, anterior cingulate cortex; PMDD, premenstrual dysphoric disorder.
Figure 5 Connectivity. Connectivity analyses revealed a pattern of positive connectivity between BOLD reactivity in emotion processing and
controlling areas in PMDD between the (A) amygdala and ACC (two clusters marked in red and yellow respectively: 3, 27, 15; k = 90; z = 3.53;
p <0.001; and 12, 44, 3; k = 29; z = 2.68; p <0.016) and the (B) insula and ACC (two clusters marked in red and yellow respectively: 15, 33, 23; k = 7;
z = 2.45; p = 0.008; and 6, 29, −4; k = 11; z = 2.46; p = 0.007). (C) For healthy controls there was a trend towards a negative relation between the
ACC and insula (6, 33, 18; k = 9; z = 1.89; p = 0.029). All anatomic localizations are given in Talairach coordinates. Brighter colors represent higher t
scores. Below the brain images, schematic representations of the connectivity are given for each cluster. Three outliers with BOLD reactivity >2
SD from mean of group were excluded from analyses. ACC, anterior cingulate cortex; PMDD, premenstrual dysphoric disorder.
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reported that increased insula activation occurred sim-
ultaneously as ACC activity decreased, supporting an
intrinsic relationship between the insula and the ACC.
Conceptually similar results were reported for patients
with social anxiety disorder, with decreased connec-
tivity between the amygdala and rostral parts of the
ACC to disorder-relevant stimuli [50], while studies in
major depression report both reduced and enhanced
connectivity between the ACC and amygdala [51]. The
ACC areas with attenuated reactivity and compro-
mised connectivity that was observed in our study are
associated both with voluntary efforts to suppress
emotional reactions [5] and with more automated
regulatory processes [52,53]. Based on the present re-
sults, we cannot determine if voluntary or automated
processes are implicated. Collectively, however, datasupport the bottom-up initiation of emotional reactions,
rather than top-down control, in response to negative
social stimulation in PMDD.
We did not seek to define the mechanisms through
which luteal phase-determined corticolimbic processes to
social stimuli in PMDD are altered. However, it could be
that the subjective experience of social as compared to
non-social stimuli in PMDD per se is of greater relevance
to the patients and thus determines the increased amygdala
reactivity. In support of this, we observed significant differ-
ences in subjective distress elicited by social but not non-
social stimuli in the luteal phase between women with
PMDD and healthy controls. However, patients with
PMDD consistently rated social stimuli as more negative
than non-social stimuli across both cycle phases, making it
unlikely that alteration in experience is the sole mechanism
driving the change in corticolimbic processing. In addition,
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did not correlate with alterations in affective ratings, but
with progesterone levels. It is possible that amygdala
reactivity in PMDD is a more sensitive measure than
subjective ratings. This is in parallel to increased amyg-
dala reactivity to emotional stimuli, without any relation
to subjective reports, previously observed for carriers of
the short version of the serotonin transporter promoter
length polymorphism [54,55]. Our study may implicate
that an overly sensitive threat detection system directed
towards social stimuli could be a prerequisite for negative
social interactions in PMDD during the luteal phase.
Another potential mechanism that may influence amyg-
dala sensitivity over the menstrual cycle is alterations in
progesterone levels [5,32]. Progesterone increased to a
similar extent between the follicular and luteal phase
both in women with PMDD and in healthy controls, but
the increase in amygdala reactivity and the corresponding
change in progesterone levels were positively correlated
only in women with PMDD. Analyses disentangling
phase-determined alterations in affective ratings from
progesterone changes further supported the notion that
hormonal alterations and not subjective experiences
were coupled to amygdala reactivity. This indicates that
individual differences in central nervous system activity
over the menstrual phase are linked to ovarian steroid
hormones rather than subjective experiences. As pro-
gesterone levels did not increase more in PMDD than
healthy controls and since no change in ACC reactivity
was observed across phases, data support the theory
that PMDD symptomatology reflects increased amyg-
dala sensitivity to progesterone [56].
Limitations of this study included the relatively few
participants and the lenient statistical threshold, warrant-
ing replication in a larger sample before the hypothesis
of socially determined corticolimbic alterations in PMDD
can be confirmed. Furthermore, only the contrast between
social and non-social images with negative valence was
analyzed, and future studies could disentangle the effect
of each stimulus type by contrasting both types of images
to more neutral slides. Strengths include the careful
diagnostic procedure with prospective ratings of PMDD
symptoms and direct estimates of progesterone as well
as a methodology focusing on a theoretically defined brain
territory with corresponding statistical small volume cor-
rections for multiple comparisons.
Conclusions
This pilot study indicates that aversive and socially rele-
vant stimuli as compared to non-social aversive stimuli
enhanced activity in affective processing brain regions that
were functionally coupled to cognitive control areas with
compromised activity. We therefore argue that patients
with PMDD are characterized by altered corticolimbiccircuit processing specifically in response to social emo-
tions, and that progesterone in part influences corticolim-
bic processing by tuning emotion processing areas.
Additional files
Additional file 1: A schematic example of the used paradigm. The
paradigm included exposure to emotional images of negative or positive
valence that were preceded by a cue indicating the upcoming valence.
In our study, only BOLD reactivity while viewing images of negative
valence with social and non-social content was studied.
Additional file 2: Table S1. Valence and arousal ratings. A table including
the ratings of pictorial stimuli on the IAPS nine-point visual analog scale for
women with PMDD and healthy controls across the menstrual cycle.
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